LDR brachytherapy of "low risk" prostate cancer: Update of the 5-year experience in 118 patients

被引：0
作者：
Block, T.
Zimmermann, F.
Czempiel, H.
机构：
[1] Urol Praxis, Vaterstetten, Germany
[2] Tech Univ Munich, Klin Strahlentherapie & Radiol Onkol, D-8000 Munich, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2007年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
[21]   Treatment and 5-Year Survival in Patients With Nonmetastatic Prostate Cancer: The Norwegian Experience EDITORIAL COMMENT [J].
Prasad, Sandip M. ;
Sartor, A. Oliver ;
Bennett, Charles L. .
UROLOGY, 2014, 83 (01) :152-153
[22]   Low-dose rate brachytherapy with I-125 seeds has an excellent 5-year outcome with few side effects in patients with low-risk prostate cancer [J].
Rasmusson, Elisabeth ;
Gunnlaugsson, Adalsteinn ;
Kjellen, Elisabeth ;
Nilsson, Per ;
Einarsdottir, Margret ;
Wieslander, Elinore ;
Fransson, Per ;
Ahlgen, Goran ;
Blom, Rene .
ACTA ONCOLOGICA, 2016, 55 (08) :1016-1021
[23]   Early prostate cancer:: LDR prostate brachytherapy with 125I permanent implantation;: Experience at CROB [J].
Cocco, G. ;
Iadanza, L. ;
Zucca, S. ;
Castaldo, G. ;
Lapadula, L. ;
Montagna, A. ;
Mazziotta, M. ;
Imbriani, E. ;
Silvestre, G. ;
Fusco, V .
ANNALS OF ONCOLOGY, 2006, 17 :XI80-XI80
[24]   Biochemical Control and Toxicity Outcomes of SBRT vs LDR Brachytherapy in the Treatment of Low and Intermediate Risk Prostate Cancer [J].
Gogineni, E. ;
Rana, Z. H. ;
Cai, H. ;
Soberman, D. ;
D'Andrea, V. ;
Lee, L. ;
Potters, L. ;
Parashar, B. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03) :E862-E862
[25]   LDR BRACHYTHERAPY WITH SEEDS AS MONOTHERAPY IN EARLY PROSTATE CANCER - THE LUND-MALMO EXPERIENCE THE 100 FIRST PATIENTS [J].
Einarsdottir, M. ;
Blom, R. ;
Bratt, O. ;
Ahlgren, G. ;
Leek, H. ;
Lamm, I. L. ;
Wieslander, E. ;
af Rosenschold, P. Munck .
RADIOTHERAPY AND ONCOLOGY, 2008, 88 :S333-S333
[26]   Nocturnal home haemodialysis: an update on a 5-year experience [J].
Pierratos, A .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (12) :2835-2840
[27]   Biochemical outcome following interstitial low dose rate (LDR) prostate brachytherapy in intermediate and high risk patients [J].
Khaksar, S. ;
Sooriakumaran, P. ;
Henderson, A. ;
Langley, S. ;
Laing, R. .
EJC SUPPLEMENTS, 2005, 3 (02) :241-242
[28]   LDR versus HDR brachytherapy boost in prostate cancer patients - a retrospective analysis [J].
Rodda, S. ;
Murray, L. ;
Bottomley, D. ;
Bownes, P. ;
Wilkinson, C. ;
Adiotomre, E. ;
Al-Qaisieh, B. ;
Dugdale, E. ;
Hulson, O. ;
Mason, J. ;
Smith, J. ;
Henry, A. M. .
RADIOTHERAPY AND ONCOLOGY, 2019, 133 :S587-S587
[29]   Ten-year outcomes using low dose rate brachytherapy for localised prostate cancer: An update to the first Australian experience [J].
Wilson, Craig ;
Waterhouse, David ;
Lane, Stephen E. ;
Haworth, Annette ;
Stanley, John ;
Shannon, Tom ;
Joseph, David .
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2016, 60 (04) :531-538
[30]   COLORECTAL-CANCER - 58 PATIENTS, A 5-YEAR EXPERIENCE [J].
DENER, C ;
TUMER, AR ;
SAHIN, M ;
KAMA, NA .
BRITISH JOURNAL OF SURGERY, 1995, 82 :25-26
12345